GE HealthCare Technologies Inc. (NASDAQ:GEHC) sheds $1.7 billion as HCA warning tests order-growth case

New York, July 14, 2026, 16:10 (EDT)

Shares of GE HealthCare Technologies slid 5.6% to $61.66 on Tuesday, wiping about $1.7 billion from its market value, after HCA Healthcare Inc. NYSE:HCA disclosed lower surgery volumes and a roughly $400 million hit from a weaker payer mix. The price action turned a hospital-operator warning into a test of GE HealthCare’s equipment order book.

GE HealthCare fell 1.46 percentage points more than the iShares U.S. Medical Devices ETF (NYSEARCA:IHI) and nearly 6 points more than a rising S&P 500. Its decline sat between Intuitive Surgical Inc. NASDAQ:ISRG and Medtronic plc NYSE:MDT, suppliers more directly tied to medical procedures. The market traded an imaging-heavy company much like a surgery stock.

That is a sharp read-through. Imaging and Advanced Visualization Solutions generated $3.64 billion, or about 71% of GE HealthCare’s first-quarter revenue, but orders on an organic basis — excluding acquisitions and currency swings — rose only 1.1%, against 10.3% a year earlier. Backlog stood at $21.8 billion and book-to-bill — orders divided by sales — was 1.07. The July 29 earnings report now carries more weight.

HCA’s preliminary second-quarter data were mixed. Same-facility admissions rose 2.5% and emergency-room visits increased 3.6%, while inpatient surgeries fell 2.3% and outpatient surgeries dropped 3.4%. More uninsured patients and a less favorable service mix cut pretax income by about $400 million, the hospital operator said. Patients are still coming through the doors; the revenue mix is weaker.

HCA cut its full-year earnings forecast to $28.70-$30.50 a share from $29.10-$31.50. Chief Executive Sam Hazen said the company had “adjusted our guidance to reflect these factors,” while Morningstar Inc. NASDAQ:MORN analyst Julie Utterback said “momentum is stalling.” The signal is about hospital cash generation as much as patient volume. Reuters

At Tuesday’s close, GE HealthCare traded at about 14.8 times trailing earnings, down from roughly 15.7 times at the previous close using the same reported earnings figure. The shares ended only 5% above their 52-week low of $58.75, while Intuitive Surgical and Medtronic retained materially higher multiples. Nearly one full valuation turn disappeared in a session.

GE HealthCare Chief Executive Peter Arduini said in April that its revenue outlook rested on “healthy customer demand globally.” After lowering its profit forecast because of input-cost inflation, the company retained its projection for 3% to 4% organic revenue growth and adjusted earnings of $4.80 to $5.00 a share. It now has to defend the demand side of that forecast. GE HealthCare

But HCA is one operator, even if it is a large one, and its admissions and emergency-room volumes continued to rise. GE HealthCare entered the quarter with a backlog slightly larger than its $20.6 billion annual revenue base, although backlog is not a one-year sales forecast. If HCA’s pressure is mainly tied to its payer mix, Tuesday’s read-through to imaging investment may prove too harsh. The bearish case still needs confirmation.

GE HealthCare reports second-quarter results before the market opens on July 29. Investors will look for U.S. order growth, backlog conversion and signs that hospitals are delaying large imaging projects after HCA’s warning. Timing matters here.

Related articles: NASDAQ:GEHC

29 July 2026

GE HealthCare shares surge after second-quarter results top forecasts; orders hit new peak